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* Five out of six deaths one 
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Ventricular septal defect (VSD) is a defect in the interventricular septum of the heart 
resulting in the left to right shunting of blood. This defect can be either in the 
perimembranous or in the muscular component of the interventricular septum (see 
Morphology). 
VSD is the most common congenital defect in children; an incidence of up to 50% of 
all congenital heart defects has been reported.' It comprises 0.3 - 0.5 / 1000 live births 
and premature infants have a tenfold increase in incidence.' 
Perimembranous VSDs account for 75% of all VSDs, muscular VSDs for 
approximately 15% and endocardial cushion defects the least common VSDs 
at 5 - 10% incidence. ' 
The natural history of ventricular septal defects is a tendency towards spontaneous 
closure, especially for small defects lying close to the tricuspid valve. 1 
The probability of spontaneous closure of a lar~e perimembranous VSD according to 
the age of the patient is illustrated in Fig. 1.1 2. 
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Fig. 1.1 Probability of spontaneous closure of large VSD according to age 
(From: Kirklin J W, Barret-Boyes B G. Cardiac surgery: Morphology, Diagnostic 
criteria, Natural history, Techniques, Results and Indications. Second Edition, page 






















The current suture technique of choice at Red Cross Children's Hospital, is a 
continuous, horizontal mattress suture. This suture technique is compared to the 
well-described interrupted pledgetted suture technique still used in many 
centres. I, \see chapter 5). 
With the trend towards earlier closure ofVSDs in younger children and infants, a 
short surgical time is an important advantage in reducing the morbidity and mortality. 
This is particularly true in the under-one-year-old high risk age group, who are 
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Prompt closure of large VSDs for clinically suspected pulmonary hypertension or 
documented elevation in pulmonary vascular resistance at cardiac catheterization, is 
indicated to avert inoperability (see fig 2.2 i and Eisemnenger Syndrome, which will 
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Fig. 2.2 Actuarial survival of patients with large VSDs after developing severe 
PHT. 
(From Kirklin J W, Barret-Boyes B G. Cardiac surgery: Morphology, Diagnostic 
criteria, Natural history, Techniques, Results and Indications. Second Edition, page 











Table 2.1 shows the figures as measured at cardiac catheterization that are generally 
accepted to quantify the severity of pulmonary vascular disease. 3 
Table 2.1 Grading of pulmonary vascular resistance 
(PVR = (Ppa - Pia) IQp} X B.S.A} 
PVR Cunits.m2) Description 
< 4 .......... .. ... ..... .. ... Normal 
4 - 5 ...................... Mildly elevated 
5 - 8 ............ .......... Moderately elevated 
> 8 ......................... Severely elevated 
(From: Kirklin J W, Barret-Boyes B G. Cardiac surgery: Morphology, Diagnostic 
criteria, Natural history, Techniques, Results and Indications. Second Edition, page 
771. Churchill Livingstone, New York, 1993.) 
Patients with elevated PVR at cardiac catheterization are further subjected to oxygen 
or Nitric oxide to assess reversibility and feasibility of surgical cure. 
Early closure of a large VSD causing elevation in pulmonary vascular resistance is 
imperative. Numerous studies have consistently documented a reduction in pulmonary 
vascular resistance and normalization of pulmonary artery pressures after closure of 
the VSD.2, 3, 6, 9, II, 14 
However, with persistent or irreversible PVR of > 8 units/m2, the closure of a VSD is 
not advised, as severe RV failure in the immediate post operative period could prove 
fatal. 3 Even so, some centres have reported operating successfully on patients with 


































































The electrocardiogram shows a normal axis with biventricular enlargement (fig. 3.1) 
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Fig. 3.1 Typical ECG of patient with VSD showing normal axis and biventricular 
enlargement 
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A posterolateral and lateral CXR shows pulmonary plethora, biventricular 
enlargement and enlarged pulmonary artery (fig. 3.2.1/2) 
Fig. 3.2.1: PA CXR of patient with VSD showing biventricular enlargement, 
pulmonary plethora and enlarged main pulmonary artery (incidental associated 











Fig. 3.2.2: Lateral CXR of patient with VSD showing biventricular enlargement, 
pulmonary plethora and enlarged main pulmonary artery (incidental associated 






























































Fig. 4.1 Different components of the interventricular septum 
(From: Anderson R H, Becker Anton E. The Heart, structure in health and disease. 













4.1 Anatomical classification of VSDs 
There is no real consensus on a standard classification ofVSDs, since terminology 
and definitions vary considerably between anatomists. 1,3,20 
Anderson and Bekker's classification gives the surgeon a good practical 
understanding of the anatomical location of isolated VSDs and classifies ventricular 
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The subdivisions of both perimembranous and muscular VSDs are based on the 
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Fig. 4.2 Subdivision of perimembranous and muscular VSDs 
(From: Anderson R H, Becker Anton E. The Heart, structure in health and disease. 











A. THE PERIMEMBRANOUS VSD 
i. Perimembranous inlet VSD 
This VSD is the result of a failure of the primitive interventricular septum to fuse with 
the endocardial cushions. 19 
The anatomic location of the VSD is beneath the septal leaflet of the tricuspid valve, 
with the medial papillary muscle (muscle of Lansici) above and to the left of the 
defect when viewed from the right atrium. 1 
The septal leaflet may, on occasion, harbour a cleft, though this is generally 
associated with an A V canal (endocardial cushion) defect. J, 20 
An important consideration in the repair of perimembranous inlet VSDs, is the 
particular vulnerability of the penetrating atrio-ventricular bundle (bundle of HIS) 
located on the postero-inferior aspect ofthis VSD. 1, 20 
ii. Perimembranous outlet VSD 
This defect probably results from a failure of fusion between the primitive 
interventricular septum and fibrous membranous continuity of the aortic valve. 19 
The VSD is typically located underneath the antero-septal commisure of the tricuspid 
valve, with the medial papillary muscle of Lansici to the right of the VSD when 
viewed from the right atrium. l , 20 
An important consideration during surgical closure, is the close relationship of the 
aortic valve to the VSD because damage to the right or non-coronary cusps of the 
. 1 I 20 aortIC va ve may occur. ' 
iii. Perimembranous sub arterial VSD 
The basis ofthis defect is failure of the bulbospiral septum to fuse with the muscular 
septum at the crista supraventricularis, hence another term used is a supracristal 
defect. Other descriptive terms for this defect are juxta-arterial and doubly committed 
VSD. 1,3,20 
An important feature of this defect is the potential for development of aortic 
incompetence, due, possibly, to lack of support to the right (and less commonly the 




































5.1.1 Transatrial approach 
1. Indication: 
The transatrial (or right atrial) approach (fig 5.1.1) is the preferred 
approach to most isolated peri membranous or inlet muscular 
VSDS. 1,3 
Trabecular muscular and infundibular muscular defects may also be 
accessible through the right atrium, but not always. I 
11. Incision: 
The usual approach is an oblique incision in the right atrial wall, 
anterior to the sulcus terminalis, extending inferiorly toward the 
inferior vena cava. 
Access to the VSD is by gentle retraction on the anterior margin of 
the right atrium and the anteroseptalleaflet of the tricuspid valve, 
using small eyelid retractors (fig. 5 .l.I). 1 
VSD 
fossa ovalis CS 
Fig. 5.1.1 Right atrial approach showing a perimembranous VSD 
(From: Stark J, de Leva! M. Surgery for congenital heart defects. 
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Fig. 5.1.2 Right ventricular approach to subarterial perimembranous VSD 
(From: Arciniegas E. Pediatric Cardiac Surgery. pp. 148. Year Book Medical 

























































































5.4 THE RED CROSS METHOD 
A. The Incision: 
Rather than the usual oblique incision which is lower on the RA wall-see fig. 
5. 1.1, the incision is made parallel to the atrioventricular groove, anteriorly on the 
RA free wall. It begins at the RA appendage about 8-10mm from the A V groove 
and extends parallel to the groove, anterior to the Ive cannula (fig. 5.4.1). The 
reasons for this approach are: 
1. Theoretical advantage over the oblique incision in terms of late 
atrial arrhythmias. 
11. Improved exposure of the tricuspid valve. Access to the whole 
atrial septum is excellent, so that atrial defects can also be dealt 
with via this route. 










B. The Patch: Glutaraldehyde-treated autologous pericardium 
The preferred patch material at Red Cross Children's Hospital for the closure of 
YSDs, is autologous pericardium harvested after opening the sternum. 
(fig. 5.4.2 -5.4.3). 
It is held taut with forceps in a 0.6% glutaraldehyde solution for 15 seconds 
(fig. 5.4.3 - 5.4.4) to reduce contraction and is then left to soak in the solution for a 
further 5 minutes. 
It is then washed and kept in normal saline until needed (fig. 5.4.5). 
The resultant patch is stiffened and easy to use. After tailoring the patch to a size at 
least 20% larger than the defect, it is implanted. (fig. 5.4.6) 










Fig 5.4.3 Freshly harvested autologous pericardial patch 











wnFig 5.4.5 Treated pericardial patch is soaked and kept in normal saline while surgeon prepares for bypass 











C. The Suture Technique: Continuous horizontal mattress 
This is a continuous horizontal mattress suture (fig. 5.4.7). Pledgetts are considered 
unnecessary because of the inherently better purchase of this suture on the muscle. 



































It was decided to compare the current surgical technique used for the closure of 
perimembranous ventricular septal defect without major associated anomalies 
(0.6% glutaraldehyde treated autologous pericarial patch), to the previously used 
technique (double velour dacron patch) in such patients at Red Cross Children's 
Hospital. 
The purpose of this comparative analysis is to ascertain the advantages and 
disadvantages of the two techniques, looking particularly at the incidence of 
postoperative residual VSD requiring repeat surgery or long-term follow-up. 
The mortality rate of the two groups was analysed with particular reference to the 
under-one-year-old age group. Recommendations with regards to primary closure in 
the under-one-year-old, high risk age group2, 10, II, 12, 13 will be made in relation to the 
surgical technique used. 
6.2. METHODOLOGY 
A retrospective study was done at the Red Cross Children's Hospital, Rondebosch, 
Cape Town, in which two separate case-matched groups of children undergoing 
different surgical closure techniques for their isolated peri membranous ventricular 
septal defects were compared. 
6.2.1 PATIENTS 
Group I consisted of 77 children operated on between January 1987 and December 
1990. 
Group II consisted of 93 children operated on between January 1995 and December 
1998. 
The period between 1990-1994 was excluded since a wide variety of techniques were 
used, including the use of a bovine pericardial patch. This period did not offer an 
easily defined group. 
Thus, the study focussed on the Dacron patch l , 3, 8, II, 12 technique (Group I), used 
extensively during the 1980's and early 1990's at Red Cross Children's Hospital, 
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The median weight for Group I was 6.0 kgs (range= 3.1 -23 kgs) and for Group II the 
median weight was 8 kgs (range =2.6-31 kgs) . (see graph 6.3.1.2) 
The Wilcoxon rank-sum non-parametric test was used for skewed distribution of 














Box and whisker plot showing skewed distribution of weight between 
groups I and II 
The under-one-year-old subgroup had a mean weight of 5.1 ± 1.1 kg in Group I and 
5.3 ± 2.7 kg in Group II (p=0.06). (see Table 6.3 .1) 
This variable was not statistically significant; uniform distribution of variables allows 
the use of the t-test to determine statistical significance. 
Forty-three patients (56%) in Group I and 37 patients (39%) in Group II were under 
12 months of age, while 23 (30%) patients and 17 (23 %) patients were less than 5 kg 
in weight respectively. (Table 6.3.1) 
Preoperative pulmonary hypertension was present in 61 patients (78%) in Group I and 
61 patients (66%) from Group II (p=0.07). Preoperative cardiac catheterization was 
done in all Group I patients, but was done in only 26 patients (28%) in 











6.3.2 CROSS-CLAMP AND CARDIOPULMONARY BYPASS TIME 
The median cross-clamp time for Group I was 50 minutes (range = 22-110minutes) 
compared to 33 minutes (range=17-99) for Group II (p<O.OOl), according to the 
Wilcoxon rank-sum test. (Table 6.3.1 and Graph 6.3.2) 
The median CPB time was also longer for Group I at 86 minutes (range = 45-231min) 
compared to Group II at 59 minutes (range = 29-139min), with a p value of <0.001, 
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eous residual incidence 
VSD of reop. 
• Group I 35% 36% 4% 6% 
• Grou II 63% 76% 1% 1% 
Graph 6.3.3 Residual VSD: Outcome 
The 2 patients in Group I who underwent reoperation for their residual VSDs 
originally had dacron patch closure and direct suture closure of their VSDs 
respectively. The third patient in the group requiring reoperation, whose parents 











In-hospital or 30-day mortality occurred in 5 patients (7%) in Group I and only 
1 patient (1%) in Group II died (p=O.04). 
There was one late death (2%) in Group 1. Thus total mortality for Group I was II % 
(6/54) and for Group II, 1% (p=O.02). 
A subanalysis of the under-one-year-old group revealed a 7% (4/54) mortality rate in 
Group I, compared to 1% (1/83) mortality rate in Group II (p=O.08). 
Further analysis of the combined mortality of groups I and II, showed that 71 % (5/7) 
of all deaths occurred in the under-one-year-old subgroup. The combined mortality 
rate for the under-one-year-old subgroup was thus 4% (51137). (See Graph 6.3.4.1) 
<30 day Mortality Late Mortality Total Mortality 










The record of each of the patients who died was examined for possible risk factors, 
and 10 were identified (see table 6.3.4.1) 
Table 6.3.4.1 Risk factors related to mortality 
rusk factor No of patients % of total deaths P value 
Age <12 months 5 71% 
Mod. to severe PHT 5 71% 
Cross clamp time >60 min. 4 57% 
CPB time> 110 min. 4 57% 
Surgical technique (dacron) 6 86% 
Weight:::; 5 kg. 3 43% 
Single surgeon 3 43% 
Debanding for previous P AB 2 29% 
Infective endocarditis 2 29% 
Junctional ectopic tachycardia 1 14% 
6.3.5 POSTOPERATIVE COMPLICATIONS 
Table 6.3.1 shows a higher incidence of post operative complications in Group Iof 
which tamponade and infective endocarditis were tending towards statistical 


















The 70% (54177) follow-up of patients in Group I was for a median period of 
40 months (range = 2-153 months), while the 89% (83/93) follow-up of patients in 
Group II was for a median period of 18 months (range = 1-60 months)(p<O.OOI). 
The combined follow-up number was 137 patients (81%), with a combined median 
follow-up period of 21 months (range = 1-153months). (Table 6.3.1 and graph 6.3.6) 
Twenty three patients in Group I and ten patients in Group II were lost to follow-up, 
i.e.33 of the total 170 patients were lost to follow-up; these patients were either 
foreign patients whose follow up records were not accessible, or local patients who 
were well and discharged early. Still others were rural patients (from outside Cape 
Town), where compliance is a major problem for various social and economic 
reasons. 
ave ff up 
tme(mnths) 
Graph 6.3.6: Follow-up data 
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septal defect is the most common congenital heart a 
tendency 3 VSDs are ,..",+,"',..,..~.rI 
are techniques. I, 3 
The current technique closure of perimembranous VSDs at Red 
Hospital, is that a 0.6% glutaraldehyde-treated autologous pericardial patch, 
with a horizontal mattress suture, a 5.0 polypropylene 
(Prolene®) suture (without pledgets), a right atrial approach. 
of 
place with alternating was 
n;,.,'""rpn option between after which time various modifications and 
were introduced. Towards latter part of 
to close perimembranous VSDs. patches were 
sewn with pledgets used to start and end the 
suture were the annulus. 
From 1994 the current technique was adopted and used exclusively; hence the VU\ ... o,",u 
study for II 1995-1998. 
dacron technique in'Group I was a right 
approach (n=67177), with total circulatory arrest commonly used 
patient was less 8kg. right (n=2177) or pulmonary approach 
was also for sub arterial perimembranous VSDs. surgical approach 
in Group II was exclusively (n=93/93) through right bicaval 
moaer'ate hypothermia an None Group II 
patients needed total circulatory arrest. This can be partly attributed to improved 
design venous cannulae; not limiting as previously. 
II ................. .., 
'-J.n." ....... I was a "'a."-' age, 
weight pulmonary hypertension (Table 7.1). 
nr11Y1".,.' repair in Group II is partly responSIble outcome 












16.8 '= 0.035 
---
Weight(kg)(median & 6 (3.1-23) • 8 (2.6-31) =0.06 
Pulmonary ertension 66177 66/93 =0.07 
high risk, 2,3,10,11,14 no 
the two with regard to (approximately 
groups), there were more under one year old patients (n=43/77) 
in Group I Group II (n=37/93)(Table 6.3.1) 
umlonary hypertension was difficult to quantitate two groups, as 
in Group II was ]argely a clinical one.17 Only 28% (26/93) of patients 
undergoing preoperative catheterization, whereas I, all 77 patients 
underwent objective measurement of their 
pulmonary advent and ease administration of nitric 
pulmonary should less a in the 
postoperative outcome of patients primary VSD closure. 28 
A highly statistical difference (p < 0.001) cross clamp 
cardiopulmonary bypass times was noted between patch III 
I and present technique Group II. 5 patients who had 
v ...... ,""v ... with bovine and 1 who had suture closure a 






























The spontaneous rate was 36% (9/25) for Group I 76% 
Group II (p<0.001). The spontaneo 
than the spontaneous closure rate quoted 
closure rate 76% in Group II is 
literature of 20-50%.2, 10,21 
.... """0·''"' ... the residual VSDs detected at ols!charge in Group II were almost all 
leaks) whilst those oT",r'I't>t1 in Group I were mostly 
left to right shunts (24/25); supporting efficacy 
Group II 6.3.3). 
(1 %) II required .. ",n .... ", ... aT1r\" compared 
to 3 patients group I (6%). mentioned "'",1',("\1"1" 
actually had reoperation. 
reported reoperation rate for VSD in 
use a Dacron 2, 8, 11, 22 Group II still fares 
,1-"',"'01-"..-", is from 3 to 5% with 
with the autologous 





tachycardia (JET) (2/82). 
to the 
58 
Groups I II (Table 6.3.1). 











Group I showed a incidence (3/48) sternal wound infection and 4% (2/49) 
incidence 4% (2/48) incidence heart 
permanent pacemaker insertion, was also seen group L One had a 
patch the other bovine with a suture 
The reported for complete block 
VSD is 1.3 to 5% related to suturing 
1,8,10,20,22 
Two patients Group I (4%) also severe permanent neurological deficit 
following cardiac arrest postoperative period. Rein et 11 showed a 1 % 
J.u .... J.U •• H ... ' ... in neurologic dysfunction following VSD 
8 a incidence 
Other postoperative 
Group I showed a 6% (3/48) of cardiac tamponade, a 1 % (1/48) incidence 
on follow-up (this patient had a dacron patch VSD closure 
ventriculotomy) a 6% incidence of 
It is worth noting that double velour was supplied in sheets, cut to the 
resterilized to costs. came 
1990 when 3 died infected dacron patches used for the closure of 
VSDs; Staphlococcus Aureus were isolated supposedly 
1J""'vH''';;) (information supplied by a at time verified 
theatre matron the time). is the 
reason for period of materials; notably, bovine pericardium. 
KCSlcnuzallon of synthetic could have potentially disastrous complications if 
to documented protocols.29, 30, 31 
A breakdown sterilization protocol in 1989/90 well contributed in 
the increased incidence of the '-IHJ"IJ I IJ'''''-''U'''' 
overall mortality Group I was 1 (6/54), to 1 % (1/83) Group II 
(p<0.02). difference in mortality could explained by higher 
operative risk of the Group I patients as mentioned earlier (younger overall 
weight possibly higher incidence higher 
group was subjected to longer cross-clamp and cardiopulmonary bypass times 
compared to Group II (p <0.001). The mortality currently reported in literature 











The under-one-year-old subgroup had a mortality rate of 7% In I, 
compared to 1%(1/83) Group II (p 0.08). One-stage closure in 
under-one-year-old age group is being increasingly advocated as mortality this 
has been considerably 6-14% 2,10,11,13 to h",j,.,,,,,,, ... 
,8,12, 13 is to better selection, improved 
operative technique, preservation, improved devices, HU;UU'"SVj,H,",,''' 
of cardiopulmonary and postoperative care. 8, 10, II, 13 
low under-one-year mortality in Group II supports this. 
The one late death Group I was not related to the VSD se, but was due to 
1""""'1""t"'1"' failure, may, in related to pUlmonary artery 
pressures. patient had a two-stage repair due to severe pulmonary 
band as a stage. Richardson et 
of12t03 for the 8 
The of both ",-jVUUO was further analysed to 
predictors of mortality, particularly parlen[S for vi>.J'OYJ'V 
age group. 
The predictors of mortality this group reported in literature are: 10,11,13 
1. age < centile 
ventilation 












study identified following risks for mortality: 
Preoperative risks: 1. Age < 12 months 517 deaths 
11. Moderate to severe - 517 
lll. Weight < 5kg 317 ... "''''''~''' 
Intraoperative risks: 
IV. Surgical ''"'Vi ...... ,.'" (Dacron patch)- 617 .... "' ... cu ... .., 
v. > 60 min - 517 .... "' ... CUi.., 
VI. time> 110 min deaths 
Surgeon 317 a aLthS 
£l.",;)V\#UU",U debanding - 217 deaths 
Postoperative complications: 
endocarditis deaths 
x. - 117 ... "'"" .... .;> 
out of the 7 .... ",,,,, .... '" overall had four or more risk factors. 
Six out of 1 0 complicating factors noted were statistically "'!",xUjL1'-"Mn 
6.3.4.1) 
table 
As earlier, 5 out of 7 patients who died were all under one old, while 













one death in II had only 2 factors, this patient was 2.7 months 
and only (below the 3rd for age). factors were keeping 
..... "'HU.H'"'U in the 10,11 as strong predictors of mortality following 
patients were the 11 ... "",,,,._,,,,, 
months) with an additiona14 or more 
incidence of residual and 3~-day mortality was statistically i:H.f',.H.l.Lllv(,IJ'" 
.... """"",><,..., the surgical techniques in I and II 
conclusion a outcome the use 0.6% glutaraldehyde-treated 
autologous pericardial patch using a continuos horizontal suture technique 













of using a autologous 
horizontal mattress suture 5.0 polypropylene 
a right atriotomy, 
morbidity and mortality. 
delnOlnstrat(~d superior results with 
trivial residual 
use of the current .vvl111Jl'-l 
knitted Dacron patch 
the low rate of reoperations 
spontaneous closure of 
l.<'::'l\.lUCU VSD supports the 
llU.lvU.v double velour when compared to use of a 
interrupted, alternating (..I""""!"'.'''''''''''' 5.0 Prolene® 
and 5.0 Ticron®. 
The technique 
washed off with 
implantation of 
technique is its simplicity with a relatively 
reducing the deleterious 
A major amlanlaJ.1~e 
x-clamp 
cardiopulmonary 'UV.11",",U by the low postoperative rate in 
group II. 
anomalies, can be 
The mortality rate can 
literature (l % 
achieve a low 
1",,..yH",.. .... is required by lU'-''''U1Y 
which have been listed in 
VSD without a'::'i:l'VvJlau.,\.l 
high 
... " .. "u" in the under-one-year-old should not be selected 
.<>V.lCl ..... 'U perimembranous VSD identifiable risk factors cannot 
the 
Optimizing nutritional status weight above 3rd centile), rpc:rnr!:lt",r, 
function (treat congestive cardiac and treat pnewnoma h.,."t"" ... .,. 
operation) and offering a quick by an 
recommendations to ensure a mortality the high risk 
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i. Data sheets of group I and group 
67 
University of Cape Town
A B C D E F G H I J K L M I N 0 P 
1 Group 1('87-'901 Name Fol.no. O.O.S Wt(kgs) PHT(clinicalJpvri) lOp. Date Xclmptm CPBtm Resvsd OIC Res vsd on ffup reap . reap dte I mortality O.O.D sto debrid 
~ 1 Smit H "'" ~0/87 ······H lyes(~1:9) 10/13/87 77 136 ,small no no no i~~st11~7) 3 2 Nkqayi K ~R?R 04/10/87 Ives(2/3) 10/06187 72 1~6 ~ .-~ ..... ... ~ - no 4 :3 MayZ 7490711061 12/10/89 4.6 no 07/31/90 65 small no 
5 4iGreyG (i9i~~ 12102/86 5,4 'yes(2/3.2) 07/14187 :~ 64 small no no no no 6 5·DavldSMo 06/16/87 4 ~:~ 





07/01/87 42 60 no no no no._ ~ ..... 
7 i Davids Mic 06/02187 4 yes(212.7} 05/26/88 62 84 small s~ 
I·· ..... -
8 no ,no no 
9 8 Davids J 70067772 03/06/87 5,8 yes(-/1,9) 01/05/88 67 1--
90 no no no no no 
9 Manhoe J 08/15/86 4,4 01/27/87 45 !small small 
... ~ .... 
10 oo~..>o no 82 no no no 
11 10 Heclor M ~~~H~~ 
02/14/87 ~1 
,,,,,,n,,l<l 09/29/87 59 62 ino no no no no 
12 11 Solomon~ 10/07/86 I'b/?\ ,g~~r/87 43 65 no ~ .. no ~~~~~ ... -
13 12 Smith 0 69283349i 01/08/87 4,7 yes(2/2,5) 16/87 56 84 no no no no no ... ~ t-r.r 13 Fati J 68673367 08/01/86 6.3 no ' 03/18/87 45 63 no Ismail no no no 
r-t5 14 Jonkers L IU::lO::lO::lU 04/24/87 5.6 yes{2/-) ~d~~~:~ '--~ 99 no no no no no ... -m --------16 15 FowierC 7~976~ ~~i~! 
4VA!:12/4,8) small no no no no 
I-:ff 16 Nkamana 71835987 4,4 vp"I'l"I<l dO 09/20/88 42 52 small no no no no 
Nlshoyiya 71864011 05113/88 5.1 YEjsf/1.4) 09/06/88 50 75 Ino 
- .. 
18 17 no no no no 
~ 18 Terblanch 70302112 08/11/87 6'yes(PABJ -----1:4i 46 90 Ismail no no no no c-.. -_. 38 47 20 19 Rixana N 71012421 02/19/87 4.7 lyes(-/4.5) no no no 21 20 iVan der Lit 72347834 06/26/88 6yes(-3.4) 34 90 small no no no no -22 21 LakayT 71862742 06125/88 4 no 11/22/88 50 80 no Ino no no no 
22 ~~~en 71289409 
04/11/88 5.7 [ ye5(3a/2.5) 11/15/88 
.. ~~ 130 
11'10 .. _ .... In!) 
.... - f----. 
no 23 no 'no 
4 23 ;~~~~ 02117/88 
5.4 I ye5(214.8) 11!Q8/88 150 small no no no no 
25 24 BrawnY ~:~ 
5 iye5(3a/4.5) 10/11/88 51 69 no no no no no 
26 .~~ Harmse T 71566590 
r-.... !f1 illest/1 ,3) . 12/~~~~ :~ 45 no no no no no .. ~- ... 27 JordaanB 71614259 08/28/87 6 I yes(3a12.4) 1 Oi/1! 93 no no no 
28 27 Beukes L 71161244 03/13/88 4, yes(3a/3.9) '06121/88 50 90 no no no no 'no 
29 28 Peters J 70240692 06/27187 4.5 yes(PAB) I 03/22188 110 203 'no no YES 03/22/88 .no·~·c· 
30 .;~ i'vInnllf1l1k" 71012421 11/13/87 3.3 yes(2/-) 02/15/88 53 1~~:~~ii no 
no no .... .... - )'~12f6/89) ~ IVan dar S( 73889842 
.. ~~:~ 5 ~::~;~~~) 12104/89 49 Ismail ,no no 32 31 Kotze B 72540016 5.1 06/27/89 60 701 no no IYES ~8f~~ no ..... 
33 32 Willemse \ 72662299 07/11/88 4.3 lyes(21-) 03/06/89 93 153,small small no no no 
34 33 ArendseA 63905483 01g9/8~ 4 no 10/03/89 45 67 no no no no no 
···-34 
7191,:~lg f---- ·4.8 1.8) 01~O/89 f----.57 110 
.-
35 Cloete L ~~~~}~~~ no no no no no , ... 36 




37 GaniefN 74904228 05/20/90 3.1 lyes(-/3.2) 07/24190 37 108 smail small no no no 
38 37 IMgijima K 74482837 06/07/89 6.5 ye5(3a/5) 04/17190 100 157 no no YES ~1190 ,no 
39 381 Baqwa 0 74344508 10/04/89 4,9 ye5(3a12.81 1A/I"I<lIQI"I 53 ;~ [no no no ... - ... 40 39 Spanenbe I 7'~934993 IUI£..>IO:1 6.3 yes(3a/2.2) JlI3I14/90 45 no I no no 
41 40 JosepheA 73867384 08/21/89 4 no 0015/90 66 112 !small no 'no no no 
• 
42 41 Bhushula ' 74064015 02/01/90 5.5 yes(-/1.5) 10/03/90 ,small no no 
43 42 Fouti D 73624173 05/03/89 6 ye~pa/-) 01/17190 70 102 Ino .... no no no no 
44 43 Susa 69054559 09/13/86 8 yes(-/3.2) ~9/87 79 118 !small small no no Ino 
45 44 68898329 09/22186 -1~·5· yes(3a/2. 1) 10/27187 J~ .. 77 no _n() no no I no. 46 45 I Baba X 70340073 08/20/85 ,ytlSlLIJ.4) 09/01/87 47 no no no 
47 46 . Maselana 69340073 06/12/85 10 .yes(-I1.6) 01/13/87 38 75 no no no - ---
Sheet2 
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no 
no no no 
no no no ----
no no no 
no no no 






























University of Cape Town
H J K I L I M I N 6 p 
Ino no 
no 1 1 1no no 
no no 
no no 
laq;l~ YES I 06123187 no no 
no no I no no 
no no I no no 




no no no no 
.......... ---no no no no 
no no no no 
no no 
large 'yES no ~ no no 
no no YES(resp 11/11/89 no 
no no 
I~o no no nail no no no 
!no no YES 07f31!89 no 
no no 
no 
------------~ no no 
small 1no 1 Ino no 





University of Cape Town
S T U V W x y Z 
no no no no SV 05122187 o PAa 
no no no no JO 06/04/90 20 no .-
~ no no no UVO 12125187 o no 
no no no UVO 12128187 o no 
no yes JO 07124/87 5 Direct suture 
no no UVO 01111188 6 no 
no no SV 01/11/87 4 no 
no Ino JO 03/17/89 19 no 
no ino JO 05/06/87 o no 
no no JO 10128188 o no 
no no 1~~6 05122/89 6 no no no 10131/97 108 debandin~ 
no no JO 04/12/91 
...... ~ no 
no JO 04110/90 24 PFO 
no BR 03115188 o no 
no UVO 06/30/95 84 no 
no JB 03106188 























6 Ino I 08/12/96 39 70 trivial no no no no 
6.3 lyes(2/S) I 05/20196 25 54 no no no no no ---
3.8 no I 11/12/96 29 58 trivial no no no no .. 
no no no na 
na no no no 
641trivial no no no no 
7411rivial no no na no 
trivial no no no no 
72 trivial no no no no 
55ltrivial Ina 
tsmall Ino I no no 
no no I no na 
large Ives x )8/18/97& 1 no na 
no na 
no Ino no I no 
small no no no 
YES I 07/23/98 
no I no 
no Ino na I na 
Ino !no ~ 
na no no 
no no no 
11/28/95 57 91 trivial Ino no no 
08/21/95 24 47 na no no no 
05/09/95 57 78 trivial na na Ina 
09/12/95 
09/26/95 41 fl trIVIal no 
09119195 17 29 no no no I no no 
01f17f95 18 42 no no Ino na na 
10f24/95 42 71 trivial Ina Ino 
06/12/95 30 49 Irivial small 11'10 Ino ino 
~ 40 68 Ina j!!Q. 1.!!2 
Sheel1 
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z AD 
no no Ino no 
no no no 
no no no no 
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02113/96 54 117 trivial no no no no 
02/27196 46 73 no no no no no 
04/17196 40 69 no Ino no no 
07/15196 36 56 trivial small Ino no 
07/23196 51 78 no Ino no no 
10/27197 20 41 trivial Ino no no 
11/24/97 191 44 no no no no 
07109197 241 37 no Ino no 
08124/9; 
.08118194 12! U 1l"LI'df 3:31 0\:1 triVIal no no 
~~:; 31 Iyesl rib) 02/18197 33 52 no no no 6.3 Iyesl [2/3.1) 02/10/97 39 57 trivial no no I no I Ino 
03/23195 10.5 rPAB) yest 01121/97 42' 58 trivial no no no I tno 
12110194 10.7 (0.1101 U.;)/<:OI::l 91 133 trivial no Ino I no I Ino 
06/21/91 14 no 04/29/97 38 67 no no Ino 1 no I lno 
04/20/95 10 yes(PAB) 05/26/97 no no Ino 
01/12/89 20 no 03/25/97 62 88 trivial 
08/05/93 12 no 03112197 53 95 trivial 
12/19/88 25 no 11/02/98 81 134 trivial 
01/09/93 17 no 10/20/98 52 76 no 
07/23/97 4.8 lyes(2/4.2) I 07/20198 36 56 trivial 
77IFelix M 84239789 11/04/96 12 yes(2/2.6) 07/20/98 18 35 trivial 
78 Saul M 72476443 05/20/88 23 yes(2) 09/22/98 40 81 trivial 
~ ~gasA 80738446 06/10/94 15 yes(1b) 06/29/98 23 43 no 
80 Edon E 82636374 02/21/96 8 yes(1b) 04/28198 26 51 trMaI 
~ 
~W~N 82537481 i 01/04/96 9 vt:!,,,{PARI 11/04/98 63 90 trivial 
iMama B 73431728 04/27/89! 19 yes(1c) , 09/02198 1 36 60 trivial 
83 Daslile N I 758836451 03/06/90 1 25 no 09/08198 1 76 97 no 
84 SaulsC 721098381 08/24188' 26 no I 07/28/98 30 54 trivial 
03117/95 4.8 yes(PAB) 06/15/98 68 102 trivial 
06/20/90 21.2 no 05/25/98 37 56 trivial no no I Ino 
10/03/97 6.5 yes(214} 12/07/98 30 52 trivial no no no 
09/26/96 7.4 ivesI2/2.3\ 04/06198 40 64 no no no no 
~ ~ i ';';;;;;{"<\-':"I?At 1 03/02/98 30 48 trivial no Ino 
99 1,,)::1 IfIVICII Ino no no !no 
27 45 trivial Ismail no no no 
30 50 no no Ino no no 
24 50 trivial I no no 
Sheet1 
University of Cape Town
Q R S T I u v W x y Z AA I AC I AD 
48 no no no no Ino Ino JH 07/11/95 1 no 401 64.633331 
49 no no no no no no JH 01/11/96 2 no 711 67.1' 
50 no no no no Ino no JH 04/10/97 7 PDA 210 17.566671 
51 no. no no no no no JH 11/05/991 39 no '1151 21.51 
52 no no no Ino no no MW 01111199 251AI 756 78.96667 1 
53 no 'no Ino ino no Ino JH 12/11/98 28 no 
, 
838 24.43333! I 
54 no 'no no Ino no no JH 06/01/98 21 no ! 615 42.71 ~ 
55 no no no no no no JH 11/26/96 9 no 283 21.733331 
56 no no no no no no JH 02128/97 10 AI 319 116.9333 
57 no no no Ino no no JH 05108/00 52 1555 54.1 
58 no no no no no no JB I 01103/97 11 mild PS 305 31.7 
59 no no no no no Ino JH 05/20/99 37 DCRV 1113 46.13333 
~ yes(9/11/9 no no no no no JH 08/01/971 12 DCRV 346 63.96667 
61 no no no Ino no no JH 11/23199 40 Ino 1200 13.36667 
62 no no no no no Ino IJH 11105/99 25 IF'PS .--.l~ 7.233333 
63 no no no Ino no no JH 02/19/99 17 AI 505 60.16667 
64 no no no no no Ino JH 05/08/00 34 no 1019 15.83333 
65 no no no no no no JH 09109197 o no 16 21.3 
66 no Ino no Ino Ino Ino JH 03/03/00 31 debanding 909 35.63333 
67 no no ~. no no no JH 04/17/00 38 no 1139 147.3333 
68 no no no Ino no no JH 05/01/001 39 no 1161 16.83333 
69 no no no no no no JH 08/02197 6 idebanding 161 22.33333 
70 no no no no no no JH 05/14/98 14 debanding 408 27.9 
71 no _c!l.0. no no no no JB 11/29/99 19 AI 570 71.3 
..g no Ino no no Ino no JH 07/03/98 12 debanding 337 25.56667 
73 no no no no nei no JH 06/03/99 26 AI 758 99.8 
74 no no no no no no JH 05/05/00 38 AI 1133 43.83333 
75 ino no no no no no ZK 01/17/00 14 AI 435 120.1667 
76 no Ino no no no no ZK 05/25/00 19 AI 575 70.33333 
77 no I yes no no Ino no JH 08/31/98 1 PFO 41 12.06667 
78 no no no no no no IJH 11/16/98 4 no 116 20.76667 
79 no Ino no no no no ZK I 05/11/00 20 no 589 125.9 
80 Ino Ino no no Ino no JH 08/18/991 14 AI 409 .dQ<tii::l::l 
81 no no no no Ino no JH 11/23/981 7 DCRV 205 26.56667 
82 no no no no no no ZK 12110/98 1 debanding 36 34.5 
83 no no no no no no ZK I 10118/99 13 mildPS I 406 113.8333 
84 no no no no no no ZK 09/06/99 12 mildPS 358 103.6 
85 no no no no no no JH 05/11/00 21 DCRV 622 120.8333 
86 no no no no no no JB 04/10/00 22 debanding 655 39.53333 
87 no no no no no no JB 03/11/99 14 IQQf!V 406 96.53333 
88 no no no no no no JH 04/22199 4 no 135 14.33333 
89 no no no no no no JH g;:~;~: 16 DCRV I 500 18.56667 90 no no no no no no JH o PFO 8 14.73333 
91 no no no no Ino Ino ZK 01/19/00 17 no 524 21 i 
92 no no no no Ino Ino IJH 04/12/99 12 AI 375 24.26667 
93 no 'no Ino .no Ino Ino IJH 03/27/00 28 DCRV 847 40.566671 
94 no Ino Ino no II Ino IJH 01131198 o DCRV I 5 50.81 
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